Polypharmacy in older adults: the role of the multidisciplinary team

References

• Levy HB. Polypharmacy reduction strategies: tips on incorporating american geriatrics society beers and screening tool of older people’s prescriptions criteria. Clin Geriatr Med. 2017 May;33(2):177–187.
   PubMed Web of Science ®Google Scholar
• Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014 Jan;13(1):57–65.
   PubMed Web of Science ®Google Scholar
• Mair A, Fernandez-Llimos F, Consortium S. Polypharmacy management programmes: the SIMPATHY Project. Eur J Hosp Pharm. 2017 Jan;24(1):5–6.
   PubMedGoogle Scholar
• Rochon PA, Gruneir A, Gill SS, et al. Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy. J Am Geriatr Soc. 2013 Jan;61(1):55–61.
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005 Sep;53(9):1518–1523.
   PubMed Web of Science ®Google Scholar
• Mixon AS, Yeh VM, Simmons S, et al. Improving care transitions for hospitalized veterans discharged to skilled nursing facilities: a focus on polypharmacy and geriatric syndromes. Geriatrics (Basel). 2019 Feb 9;4(1):19.
   PubMedGoogle Scholar
• Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990 Apr;150(4):841–845.
   PubMed Web of Science ®Google Scholar
• Garpestad E, Devlin JW. Polypharmacy and Delirium in Critically Ill Older Adults: recognition and Prevention. Clin Geriatr Med. 2017 May;33(2):189–203.
   PubMed Web of Science ®Google Scholar
• Kanaan AO, Donovan JL, Duchin NP, et al. Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. J Am Geriatr Soc. 2013 Nov;61(11):1894–1899.
   PubMed Web of Science ®Google Scholar
• Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010 Jul 12;170(13):1142–1148.
   PubMedGoogle Scholar
• Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995 Oct 9;155(18):1949–1956.
   PubMed Web of Science ®Google Scholar
• Kanagaratnam L, Drame M, Novella JL, et al. Risk factors for adverse drug reactions in older subjects hospitalized in a dedicated dementia unit. Am J Geriatr Psychiatry. 2017 Mar;25(3):290–296.
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society. American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019 Apr;67(4):674–694.
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
   PubMed Web of Science ®Google Scholar
• Mansukhani RP, Bridgeman MB, Candelario D, et al. Exploring transitional care: evidence-based strategies for improving provider communication and reducing readmissions. P T. 2015 Oct;40(10):690–694.
   PubMedGoogle Scholar
• Kripalani S, LeFevre F, Phillips CO, et al. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. Jama. 2007 Feb 28;297(8):831–841.
   PubMed Web of Science ®Google Scholar
• Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018 Oct 11;18(1):239.
   PubMedGoogle Scholar
• Jun K, Hwang S, Ah YM, et al. Development of an anticholinergic burden scale specific for korean older adults. Geriatr Gerontol Int. 2019 Jul;19(7):628–634.
   PubMed Web of Science ®Google Scholar
• TJ W, van der Wardt V, Ojo G, et al. Anticholinergic drug burden tools/scales and adverse outcomes in different clinical settings: a systematic review of reviews. Drugs Aging. 2018 Jun;35(6):523–538.
   PubMed Web of Science ®Google Scholar
• Bourcier E, Baptiste A, Borowik A, et al. Sedative-hypnotic initiation and renewal at discharge in hospitalized older patients: an observational study. BMC Geriatr. 2018 Nov 14;18(1):278.
   PubMedGoogle Scholar
• Pek EA, Remfry A, Pendrith C, et al. High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults. J Hosp Med. 2017 May;12(5):310–316.
   PubMed Web of Science ®Google Scholar
• Yu NW, Chen PJ, Tsai HJ, et al. Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case-control study in Taiwan. BMC Geriatr. 2017 Jul 11;17(1):140.
   PubMedGoogle Scholar
• Kaufmann CN, Spira AP, Alexander GC, et al. Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists. Am J Emerg Med. 2017 Oct;35(10):1414–1419.
   PubMed Web of Science ®Google Scholar
• Chang CM, Wu EC, Chang IS, et al. Benzodiazepine and risk of hip fractures in older people: a nested case-control study in Taiwan. Am J Geriatr Psychiatry. 2008 Aug;16(8):686–692.
   PubMed Web of Science ®Google Scholar
• Chen PJ, Yu NW, Tsai HJ, et al. Hospitalized burn injury risk associated with benzodiazepines and Z-drugs in elders: A population-based case-control study. Int J Geriatr Psychiatry. 2019 Oct;34(10):1465–1472.
   PubMed Web of Science ®Google Scholar
• Soong C, Burry L, Cho HJ, et al. An Implementation Guide to Promote Sleep and Reduce Sedative-Hypnotic Initiation for Noncritically Ill Inpatients. JAMA Intern Med. 2019 Jul 1;179(7):965–972.
   PubMed Web of Science ®Google Scholar
• Herzig SJ, Rothberg MB, Guess JR, et al. Antipsychotic medication utilization in nonpsychiatric hospitalizations. J Hosp Med. 2016 Aug;11(8):543–549.
   PubMed Web of Science ®Google Scholar
• Nikooie R, Neufeld KJ, Oh ES, et al. Antipsychotics for Treating Delirium in Hospitalized Adults: A Systematic Review. Ann Intern Med. 2019 Sep;171(7):485–495.
   Web of Science ®Google Scholar
• Lee KS, Kim SH, Hwang HJ. Behavioral and psychological symptoms of dementia and antipsychotic drug use in the elderly with dementia in korean long-term care facilities. Drugs Real World Outcomes. 2015 Dec;2(4):363–368.
   PubMedGoogle Scholar
• Jessop T, Harrison F, Cations M, et al. Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2017 Aug;29(8):1391–1403.
   PubMed Web of Science ®Google Scholar
• Yu F, Rafizadeh R, Mabasa VH, et al. Risk Evaluation for Antipsychotic Agents Used in Elderly Inpatients (REPAIR). Can J Hosp Pharm. 2018 Nov-Dec;71(6):370–375.
   PubMed Web of Science ®Google Scholar
• Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007 Jun 5;146(11):775–786.
   PubMed Web of Science ®Google Scholar
• Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Jama. 2005 Oct 19;294(15):1934–1943.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Setoguchi S, Brookhart A, et al. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Cmaj. 2007 Feb 27;176(5):627–632.
   PubMed Web of Science ®Google Scholar
• Kuehn BMFDA. Antipsychotics risky for elderly. Jama. 2008 Jul 23;300(4):379–380.
   PubMed Web of Science ®Google Scholar
• Mehta S, Pulungan Z, Jones BT, et al. Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1271–1280.
   PubMed Web of Science ®Google Scholar
• Wang MT, Tsai CL, Lin CW, et al. Association between antipsychotic agents and risk of acute respiratory failure in patients with chronic obstructive pulmonary disease. JAMA Psychiatry. 2017 Mar 1;74(3):252–260.
   PubMed Web of Science ®Google Scholar
• Steinberg M, Lyketsos CG. Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry. 2012 Sep;169(9):900–906.
   PubMed Web of Science ®Google Scholar
• Kim B, Nolan S, Beaulieu T, et al. Inappropriate opioid prescribing practices: A narrative review. Am J Health-system Pharm. 2019 Aug 1;76(16):1231–1237.
   PubMed Web of Science ®Google Scholar
• Veal FC, Bereznicki LR, Thompson AJ, et al. Use of Opioid Analgesics in Older Australians. Pain Med. 2015 Aug;16(8):1519–1527.
   PubMed Web of Science ®Google Scholar
• Rose AJ, McBain R, Schuler MS, et al. Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015. J Am Geriatr Soc. 2019 Jan;67(1):128–132.
   PubMed Web of Science ®Google Scholar
• Soderberg KC, Laflamme L, Moller J. Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs. 2013 Feb;27(2):155–161.
   PubMed Web of Science ®Google Scholar
• Boudreau RM, Hanlon JT, Roumani YF, et al. Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition study. Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):916–922.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Boudreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):492–498.
   PubMed Web of Science ®Google Scholar
• Puustinen J, Nurminen J, Löppönen M, et al. Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. BMC Geriatr. 2011;11:70.
   PubMed Web of Science ®Google Scholar
• Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing. 2011 Jan;40(1):23–29.
   PubMed Web of Science ®Google Scholar
• Murphy DL, Lebin JA, Severtson SG, et al. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics. Drug Saf. 2018 Aug;41(8):787–795.
   PubMed Web of Science ®Google Scholar
• Kwong WJ, Diels J, Kavanagh S. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Ann Pharmacother. 2010 Apr;44(4):630–640.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Wang X, Castle NG, et al. Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents. J Am Geriatr Soc. 2011 Aug;59(8):1412–1420.
   PubMed Web of Science ®Google Scholar
• Ray WA, Chung CP, Murray KT, et al. Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med. 2015 Mar;175(3):420–427.
   PubMed Web of Science ®Google Scholar
• Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a review. Ochsner J. 2010;10(3):179–187.
   PubMedGoogle Scholar
• Klueh MP, Hu HM, Howard RA, et al. Transitions of Care for Postoperative Opioid Prescribing in Previously Opioid-Naive Patients in the USA: a Retrospective Review. J Gen Intern Med. 2018 Oct;33(10):1685–1691.
   PubMed Web of Science ®Google Scholar
• Malanda UL, Welschen LM, Riphagen II, et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012 Jan 18;1:Cd005060.
   PubMedGoogle Scholar
• Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2011 Jun;15(6):Cd008143.
   Google Scholar
• Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019 May 2;68(10):1611–1615.
   PubMedGoogle Scholar
• Nordenstam GR, Brandberg CA, Oden AS, et al. Bacteriuria and mortality in an elderly population. N Engl J Med. 1986 May 1;314(18):1152–1156.
   PubMed Web of Science ®Google Scholar
• Ruiz-Garcia V, Lopez-Briz E, Carbonell-Sanchis R, et al. Megestrol acetate for cachexia-anorexia syndrome. A systematic review. J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):444–452.
   PubMed Web of Science ®Google Scholar
• Yavuzsen T, Davis MP, Walsh D, et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005 Nov 20;23(33):8500–8511.
   PubMed Web of Science ®Google Scholar
• Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008 Mar 4;148(5):379–397.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medication Safety in Polypharmacy. Geneva: World Health Organization; 2019. (WHO/UHC/SDS/2019.11). Available from: https://apps.who.int/iris/bitstream/handle/10665/325454/WHO-UHC-SDS-2019.11-eng.pdf?ua=1
   Google Scholar
• McIntosh J, Alonso A, MacLure K, et al. A case study of polypharmacy management in nine European countries: implications for change management and implementation. PLoS One. 2018;13(4):e0195232.
   PubMed Web of Science ®Google Scholar
• Cullinan S, Fleming A, O’Mahony D, et al. Doctors’ perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol. 2015 May;79(5):860–869.
   PubMed Web of Science ®Google Scholar
• Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–328.
   Google Scholar
• Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging de fi nition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015 Dec;80(6):1254–1268.
   PubMed Web of Science ®Google Scholar
• Liu YL, Chu LL, Su HC, et al. Impact of computer-based and pharmacist-assisted medication review initiated in the emergency department. J Am Geriatr Soc. 2019 Jul;67(11):2298–2304.
   Web of Science ®Google Scholar
• Huiskes VJ, Burger DM, van den Ende CH, et al. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017 Jan 17;18(1):5.
   PubMed Web of Science ®Google Scholar
• Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014 Oct;7(10):Cd008165.
   Google Scholar
• Johansson T, Abuzahra ME, Keller S, et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016 Aug;82(2):532–548.
   PubMed Web of Science ®Google Scholar
• Mangin D, Bahat G, Golomb BA, et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position Statement and 10 Recommendations for Action. Drugs Aging. 2018 Jul;35(7):575–587.
   PubMed Web of Science ®Google Scholar
• Stewart D, Mair A, Wilson M, et al. Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments. Expert Opin Drug Saf. 2017 Feb;16(2):203–213.
   PubMed Web of Science ®Google Scholar